Dexcom (DXCM) EPS (Diluted) Growth (5y) (2018 - 2026)
Powered by 
Analysis
Dexcom (DXCM) EPS (Diluted) Growth (5y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.62 Bn | 179.02 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.22 Bn | 119.01 Bn | 1.96 Bn |
| 3 | Medtronic | 118.38 Bn | 109.56 Bn | 6.34 Bn |
| 4 | Stryker | 104.98 Bn | 101.51 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.67 Bn | 66.13 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.77 Bn | 45.52 Bn | 1.35 Bn |
| 7 | Alcon | 34.01 Bn | 32.56 Bn | 1.68 Bn |
| 8 | Dexcom | 32.28 Bn | 30.33 Bn | 830.00 Mn |
| 9 | Steris | 21.17 Bn | 20.69 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 18.23 Bn | 17.82 Bn | 1.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.54% |
| Mar 31, 2026 | 28.96% |
| Dec 31, 2025 | -8.97% |
| Sep 30, 2025 | 30.88% |
| Jun 30, 2025 | 29.85% |
| Mar 31, 2025 | 37.37% |
| Dec 31, 2024 | 7.92% |
| Sep 30, 2024 | 21.53% |
| Jun 30, 2024 | 69.40% |
| Mar 31, 2024 | 46.37% |
| Dec 31, 2023 | 26.05% |
| Sep 30, 2023 | 17.00% |
| Jun 30, 2023 | 26.04% |
| Mar 31, 2023 | 29.60% |
| Dec 31, 2022 | 58.13% |
| Sep 30, 2022 | 112.38% |
| Jun 30, 2022 | 70.86% |
| Mar 31, 2022 | 30.74% |
| Dec 31, 2021 | 9.77% |
| Sep 30, 2021 | 42.44% |